TGFB1 and neoplasm: Second, the activation of a TGF-β responsive gene expression signature within the tumor cells and tumor stroma including tumor-infiltrating immune cells (TILs) could be used to predict the potential impact of TGF-β blockade on outcome, and the choice of other therapeutic modalities that may work synergistically with TGF-β blockage.